₹12.46
+₹1.13 (+9.97%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹244 Cr
P/E
-0.99
ROE
-9.85%
ROCE
-8.75%
About Nectar Lifescience Ltd
Nectar Lifescience is engaged in Company undertook significant restructuring and asset monetization initiatives including slump sale/business transfer arrangements relating to certain manufacturing units/ business undertakings, monetization of identified land parcels and other non-core assets.
Founded
1995
CEO
Sanjiv Goyal
Employees
1,786
HQ
Chandigarh, India
About Nectar Lifescience Ltd
Nectar Lifescience is engaged in Company undertook significant restructuring and asset monetization initiatives including slump sale/business transfer arrangements relating to certain manufacturing units/ business undertakings, monetization of identified land parcels and other non-core assets.
Founded:1995
CEO:Sanjiv Goyal
Employees:1,786
HQ:Chandigarh, India
Finished Products
1Sales
₹3,834.23CrRaw Materials
1Raw Materials Consumed
₹2,493.17CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹22
52W Low
₹9
Volume1.47M
Avg VolumeN/A
Beta1.09
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-0.99x
Valuation
P/B Ratio
0.42x
Valuation
EPS
₹-12.61
Valuation
Dividend Yield
0.00%
Valuation
ROE
-9.85%
Profitability
ROCE
-8.75%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals ProductsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
64.2%
International
35.8%
India64.2%
Outside India35.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.